Pelvic Nerve Mobilization for Primary Dysmenorrhea

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-30
SponsorUniversity of Hail

About this trial

Primary dysmenorrhea is a highly prevalent condition among young women and is associated with significant pain, reduced quality of life, and academic absenteeism. Although non-steroidal anti-inflammatory drugs are commonly used, many women seek non-pharmacological alternatives due to limited effectiveness or adverse effects. Emerging evidence suggests that altered pelvic neurodynamics may contribute to dysmenorrheic pain.

This randomized controlled trial aims to evaluate the effectiveness of external pelvic nerve mobilization in reducing menstrual pain and associated symptoms among university women with primary dysmenorrhea. Participants aged 18-30 years will be randomly allocated to receive either external pelvic nerve mobilization or a sham manual therapy intervention across three consecutive menstrual cycles. Outcomes will include pain intensity, menstrual distress, quality of life, pelvic tenderness, analgesic consumption, and academic absenteeism.

Eligibility criteria

Qualifiers

Female university students aged 18-30 years

Regular menstrual cycles (24-35 days)

Clinically diagnosed primary dysmenorrhea

Average menstrual pain intensity ≥ 5 on Visual Analog Scale

Disqualifiers

Secondary dysmenorrhea (e.g., endometriosis, fibroids, pelvic inflammatory disease)

History of pelvic or spinal surgery

Neurological disorders

Current pregnancy or lactation

Trial design

Treatments tested in this trial

  • External Pelvic Nerve Mobilization
  • Sham Mobilization

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Hail

Lead sponsor

Health Education Research Foundation (HERF)

Collaborator